Lana Chahine, MD, PhD

Title(s)Professor of Clin Neurology, Neurology
SchoolSchool of Medicine
Address1651 4th Street, #3600
San Francisco CA 94158
vCardDownload vCard

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Slow-SPEED: protocol for three randomised trials of remotely delivered exercise to prevent Parkinson's disease. NPJ Parkinsons Dis. 2026 Jul 14. Oosterhof TH, Mitchell E, Ascherio A, Aslibekyan S, Azoidou V, Beasley K, Ben-Shlomo Y, Bunnik E, Carroll C, Chahine L, Corcos D, Janssen Daalen JM, van Dijk KD, Dijkstra BW, Dommershuijsen L, Dorsey R, Evers LJW, Helmich RC, Johansson M, Norcliffe-Kaufmann L, Keavney J, Klein C, Kmiecik MJ, Kustermann T, Macklin EA, Marek K, Meles SK, Overeem S, Philpott CM, Pijpers A, Postuma RB, Rowbotham HM, Schootemeijer S, Schwarzschild MA, Simuni T, Sommerauer M, Stefani A, Steidel K, Verbeek M, van der Vliet R, de Vries NM, van de Warrenburg B, Wyse RK, Bloem BR, Schneider RB, Noyce AJ, Darweesh SKL. PMID: 42448717.
      View in: PubMed   Mentions:
    2. Brain-Aggregated and Body-Aggregated Alpha-Synuclein in Lewy Body Disease: Sowing Initial Seeds of Understanding. Neurology. 2026 Jul 28; 107(2):e218332. Coughlin DG, Chahine LM. PMID: 42348801.
      View in: PubMed   Mentions:    Fields:    
    3. A Bayesian network analysis of gait speed change upon transition to uneven surfaces in older adults. J Gerontol A Biol Sci Med Sci. 2026 Jun 06; 81(7). Song Y, Rosano C, Chahine LM, Rosso AL, Ambrosio F, Bohnen N, Chen Z, Kim S. PMID: 42184285; PMCID: PMC13287991.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative. Ann Neurol. 2026 May 18. Gonzalez-Latapi P, Gochanour C, Choi SH, Cho H, Caspell-Garcia C, Coffey CS, Lafontant DE, Xiao Y, Tanner CM, Venuto CS, Kieburtz K, Chahine LM, Poston KL, Galasko D, Picillo M, Siderowf A, Tropea TF, Simuni T, Marek K, Parkinson's Progression Markers Initiative. PMID: 42152134.
      View in: PubMed   Mentions:    Fields:    
    5. Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative. Ann Neurol. 2026 May 14. Brown EG, Chahine LM, Dobkin RD, Simuni T, Foroud T, Heathers LEA, Tropea TF, Stanley CE, McMahon BA, Brüggemann N, Klein C, Postuma RB, Johnson NS, Gochanour C, Caspell-Garcia C, Kurth R, Brumm MC, Coffey CS, Marek K, Tanner CM, Parkinson's Progression Markers Initiative. PMID: 42132059.
      View in: PubMed   Mentions:    Fields:    
    6. Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers Initiative. Ann Neurol. 2026 May 13. Weintraub D, Dobkin RD, York MK, Chahine LM, Tropea TF, Marek K, Parkinson's Progression Markers Initiative. PMID: 42125954.
      View in: PubMed   Mentions:    Fields:    
    7. Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI. Ann Neurol. 2026 May 10. Tanner CM, Stanley CE, Brown EG, Chahine LM, Weintraub D, Dobkin RD, Poewe W, Tolosa E, Marras C, Schade S, Chou KL, Pavese N, Coffey CS, Brumm MC, Kurth R, Noyce AJ, Gonzalez-Latapi P, Matthews-McGee A, Korell M, Meng C, Chen X, Racelo L, Ricci J, Fitzgerald C, Rigby NH, Battles JA, Carley JK, Singh Z, Kruchkow L, McMahon BA, Flagg E, Lemon LP, Talarico JM, Brodkin K, Destro C, Kuhl MM, Fabrizio K, Marek K, Tropea TF, Parkinson's Progression Markers Initiative. PMID: 42108656.
      View in: PubMed   Mentions:    Fields:    
    8. Practical approaches to inclusive recruitment practices in Parkinson's disease research. J Parkinsons Dis. 2026 Jun; 16(4):709-722. Chahine LM, Louie N, Disbrow E, Marbach A, Augenbraun S, Nguyen BT, Johnson-Turbes A, Parry C, Avripas S, Chandra S, Dean M, Foster ER, Hall D, Hinson V, Kilbane C, Norris SA, Rawls A, Jonas C, Shamim EA, Shulman L, Staisch J, Stimming EF, Xie T, Wilcox M, Ameri A, Breaux S, Padmanaban M, von Coelln R, Singleton A, Blauwendraat C, Bandres-Ciga S, Baykal-Caglar E, Kelliher C, Greenwood K, O'Grady A, Solle J, Kopil CM, Kuhl MM, Black and African American Connections to Parkinson's Disease (BLAAC PD) and the Global Parkinson's . PMID: 42095464; PMCID: PMC13435172.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative. Ann Neurol. 2026 May 06. Chahine LM, Alcalay RN, Brown EG, Chowdhury S, Coffey CS, Foroud T, Frasier M, Galasko D, Merchant KM, Mollenhauer B, Tolosa E, Pavese N, Tropea TF, Marek K, Simuni T, Parkinson's Progression Markers Initiative. PMID: 42089472.
      View in: PubMed   Mentions:    Fields:    
    10. Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations. Brain. 2026 May 05; 149(5):1537-1553. Akçimen F, Paquette K, Wild Crea P, Step K, Waldo E, Koretsky MJ, Saffie-Awad P, Achoru C, Taiwo F, Ozomma S, Onwuegbuzie G, Khani M, Grant S, Owolabi L, Okereke C, Oshinaike O, Iwuozo E, Akerman SC, Lee PS, Oyakhire S, Osemwegie N, Daida K, Abubakar S, Olusanya A, Isayan M, Alvarez C, Traurig R, Ogunmodede A, Samuel S, Makarious MB, Sa'ad F, Olanigan R, Levine K, Ogbimi EM, Vitale D, Odiase F, Ojini F, Odeniyi O, Fang ZH, Obianozie N, Hall DA, Nwazor E, Xie T, Nwaokorie F, Padmanaban M, Nwani P, Shamim EA, Nnama A, Standaert D, Komolafe M, Dean M, Osaigbovo G, Disbrow E, Ishola I, Rawls A, Imarhiagbe F, Chandra S, Erameh C, Hinson V, Louie N, Idowu A, Solle J, Norris SA, Ibrahim A, Kilbane C, Sukumar G, Shulman LM, Ezuduemoih D, Staisch J, Breaux S, Dalgard C, Foster ER, Bello A, Ameri A, Real R, Ikwenu E, Morris HR, Anyanwu R, Furr Stimming E, Billingsley K, Alaofin W, Alvarez Jerez P, Agabi O, Hernandez DG, Akinyemi R, Arepalli S, Malik L, Owolabi R, Nyandaiti Y, Leonard HL, Wahab K, Abiodun O, Hernandez CF, Abdulai F, Iwaki H, Bardien S, Klein C, Hardy J, Houlden H, Galvelis KG, Nalls MA, Dahodwala N, Aamodt W, Hill E, Espay A, Factor S, Branson C, Blauwendraat C, Singleton AB, Ojo O, Chahine LM, Okubadejo N, Bandres-Ciga S. PMID: 41058593; PMCID: PMC13140531.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Return of Individual Research Information in the Parkinson's Progression Markers Initiative. Ann Neurol. 2026 Apr 29. Tropea TF, Brodkin K, Brumm MC, Carley JK, Destro C, Flagg E, Heathers LEA, Henry B, Lemon LP, Kuhl MM, McMahon BA, Miller M, Myers H, Stanley CE, Talarico JM, Pico C, Chahine LM, Siderowf A, Marek K, Foroud T, Parkinson's Progression Markers Initiative. PMID: 42057343.
      View in: PubMed   Mentions:    Fields:    
    12. Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy. Ann Clin Transl Neurol. 2026 Apr 21. Weintraub D, York MK, Dobkin R, Nair AR, Kurth R, Lafontant DE, Caspell-Garcia C, Alcalay RN, Brown EG, Chahine LM, Coffey C, Foroud T, Galasko D, Kieburtz K, Marek K, Merchant K, Mollenhauer B, Poston KL, Siderowf A, Simonet C, Simuni T, Tanner CM, Tropea TF, Videnovic A, Parkinson's Progression Markers Initiative. PMID: 42015618.
      View in: PubMed   Mentions:    Fields:    
    13. Clinical Progression in Alpha-Synuclein Positive LRRK2-PD and Sporadic Parkinson's Disease: A Longitudinal Analysis. Mov Disord Clin Pract. 2026 Apr 19. Morse LA, Choi SH, Gochanour C, Lafontant DE, Chahine LM, Merchant KM, Wendelberger B, Simuni T, Parkinson's Progression Markers Initiative. PMID: 42003081; PMCID: PMC13339648.
      View in: PubMed   Mentions:    Fields:    
    14. Striatal Dopaminergic Neurotransmission, Striato-Cortical Functional Connectivity, and Motivation in Community-Dwelling Older Adults. Am J Geriatr Psychiatry. 2026 Mar 19. Song Y, Cawthon PM, Zhai X, Huppert TJ, Rosso AL, Butters MA, Chahine LM, Lopresti BJ, Royse SK, Rosano C. PMID: 41966918.
      View in: PubMed   Mentions:    Fields:    
    15. International Parkinson and Movement Disorder Society Clinical Outcome Assessments are Available in REDCap. Mov Disord. 2026 Mar 16. Fuller RLM, Monje MHG, Chahine LM, Delgado EC, Dujardin K, Elavarasi A, Fearon C, Fitzer-Attas CJ, Groppa S, Jha A, Raji HK, Nirenberg MJ, Lloret SP, Poon C, Schneider R, Turner T, Youn J, Mestre TA, Sanchez-Ferro A. PMID: 41840879.
      View in: PubMed   Mentions:    Fields:    
    16. Five-Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease. Ann Clin Transl Neurol. 2026 Mar 10. Gonzalez-Latapi P, Gochanour C, Choi SH, Cho H, Caspell-Garcia C, Coffey C, Brumm M, Lafontant DE, Xiao Y, Tropea T, Seibyl J, Tanner C, Venuto CS, Kieburtz K, Chahine LM, Poston KL, Siderowf A, Marek K, Simuni T, Parkinson's Progression Markers Initiative. PMID: 41808287.
      View in: PubMed   Mentions:    Fields:    
    17. Striatal dopamine and skeletal muscle energy metabolism in older adults. J Gerontol A Biol Sci Med Sci. 2026 Mar 10; 81(4). Rosano C, Bohnen NI, Lopresti B, Chahine LM, Barnes HN, Studenski SL, Glynn NW, Newman AB, Marcinek DJ, Hepple RT, Coen PM. PMID: 41691472; PMCID: PMC13017426.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Biological characteristics of individuals with REM sleep behavior disorder: A multicenter prospective longitudinal cohort. Parkinsonism Relat Disord. 2026 Apr; 145:108266. Feuerstein J, Brown E, Chahine L, Erick-Lafontant D, Gochanour C, Marshall M, Weintraub D, Simuni T, Amara A, Parkinson's Progression Markers Initiative. PMID: 41780487.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha-Synuclein Seed Amplification Assay. Mov Disord. 2026 May; 41(5):1114-1127. Brooker SM, Pasquini J, Choi SH, Lafontant DE, Fereshtehnejad SM, Zeighami Y, Grillo P, Riboldi GM, Azizi H, Moqadam R, Kang UJ, Nudelman KNH, Siderowf A, Tanner CM, Tropea TF, Foroud T, Chahine LM, Mollenhauer B, Merchant KM, Galasko D, Coffey CS, Dobkin RD, Brown EG, Alcalay RN, Weintraub D, Marek K, Simuni T, Gonzalez-Latapi P, Pavese N, Poston KL, Parkinson's Progression Markers Initiative. PMID: 41603617; PMCID: PMC13206160.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Carriers of LRRK2 pathogenic variants show a milder, anatomically distinct brain signature of Parkinson's disease. Commun Med (Lond). 2026 Jan 03; 6(1):71. Kopal J, Vo A, Tao Q, Simuni T, Chahine LM, Bzdok D, Dagher A. PMID: 41484352; PMCID: PMC12868736.
      View in: PubMed   Mentions:
    21. Prodromal features and risk of neurodegenerative disorders diagnosis in outpatients with REM sleep behavior disorder. J Clin Sleep Med. 2025 11 01; 21(11):1857-1869. Chahine LM, Newman A, Boyce RD, Brooks MM. PMID: 40742128; PMCID: PMC12582213.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Parkinson's disease: emerging opportunities through global collaboration. Lancet. 2026 Jan 17; 407(10525):203-205. Singleton A, Blauwendraat C, Morris HR, Noyce AJ, Klein C, Mata I, Okubadejo N, Periñan MT, Chahine LM. PMID: 41077048.
      View in: PubMed   Mentions: 1     Fields:    
    23. Features of Prodromal Parkinson Disease and Dopaminergic Neurotransmission in Community-Dwelling Older Adults. Neurology. 2025 Sep 23; 105(6):e214037. Chahine L, Rosso AL, Troidl I, Ganguli M, Newman AB, Lopresti BJ, Allen K, Royse SK, Mosovsky S, Ratner E, Dholakia G, Bohnen NI, Rosano C. PMID: 40882172; PMCID: PMC12396634.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    24. Nigrostriatal dopaminergic integrity in relation to prefrontal cortex activity and gait performance during dual-task walking in older adults. J Gerontol A Biol Sci Med Sci. 2025 08 23; 80(9). Rosso AL, Baillargeon EM, Bohnen NI, Lopresti BJ, Huppert TJ, Chahine LM, Jacobsen E, Rosano C. PMID: 40668215; PMCID: PMC12374793.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder. Ann Neurol. 2025 09; 98(3):482-491. Weintraub D, Nair AR, Kurth R, Brumm MC, Kohnen C, York MK, Dobkin RD, Marek K, Tanner C, Simuni T, Siderowf A, Galasko D, Chahine LM, Coffey C, Merchant K, Poston KL, Foroud T, Mollenhauer B, Brown EG, Kieburtz K, Frasier M, Chowdhury S, Alcalay RN, Videnovic A, Parkinson's Progression Markers Initiative. PMID: 40641332; PMCID: PMC12392052.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Reply to: "Refutation of the αSyn-SAA-Based Staging for Parkinson's Progression (Neuronal α-Synuclein Disease-Integrated Staging System [NSD-ISS])". Mov Disord. 2025 Aug; 40(8):1746-1747. Simuni T, Chahine LM, Poston KL, Kopil CM, Weintraub D, Dunn B, Marek K. PMID: 40579845; PMCID: PMC12371628.
      View in: PubMed   Mentions: 1     Fields:    
    27. Nigrostriatal dopaminergic neurotransmission and resilience to peripheral systemic risk factors for gait slowing upon transition to uneven surfaces in older adult. Aging Brain. 2025; 8:100143. Chahine LM, Rosso A, Troidl I, Ganguli M, Newman A, Cummings S, Studenski S, Lopresti B, Royse S, Huppert T, Redfern M, Sparto PJ, Bohnen NI, Rosano C. PMID: 40606490; PMCID: PMC12221426.
      View in: PubMed   Mentions:
    28. Striatal Dopamine and Skeletal Muscle Energy Metabolism in Older Adults. medRxiv. 2025 Jun 12. Rosano C, Bohnen NI, LoPresti B, Chahine LM, Barnes HN, Studenski SL, Glynn NW, Newman AB, Marcinek DJ, Hepple RT, Coen P. PMID: 40585073; PMCID: PMC12204456.
      View in: PubMed   Mentions:
    29. Mesocorticolimbic dopaminergic innervation modulates Levodopa-related improvements in gait in older slow walking Adults: A [11C]PE2I PET study. Clin Park Relat Disord. 2025; 12:100353. Paalanen N, Roytman S, Emde Boas MV, Biddix A, Luker A, Michalakis F, Carli G, Kanel P, Pongmala C, Koeppe R, Chahine LM, Rosano C, Bohnen NI. PMID: 40524948; PMCID: PMC12169706.
      View in: PubMed   Mentions:
    30. Neuronal α-Synuclein Disease Stage Progression over 5 Years. Mov Disord. 2025 Jul; 40(7):1318-1330. Simuni T, Gochanour C, Nair AR, Brumm MC, Coffey C, Poston KL, Chahine LM, Weintraub D, Tanner CM, Gonzalez-Latapi P, Kopil CM, Xiao Y, Chowdhury S, Dam T, Pagano G, Stephenson D, Siderowf A, Dunn B, Marek K, NSD Working Group the Parkinson's Progression Markers Initiative. PMID: 40302527; PMCID: PMC12273616.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    31. Predicting CSF α-Synuclein Seed Amplification Assay Status From Demographics and Clinical Data. Neurol Open Access. 2025 Jun; 1(2). Venuto CS, Herbst K, Chahine L, Kieburtz KD. PMID: 41982814; PMCID: PMC13075382.
      View in: PubMed   Mentions:
    32. Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohort. NPJ Parkinsons Dis. 2025 Apr 06; 11(1):69. Chahine LM, Brumm MC, Nair AR, Mosovsky S, Polinski NK, Beach TG, Mollenhauer B, Adler CH, Systemic Synuclein Sampling Study. PMID: 40188190; PMCID: PMC11972316.
      View in: PubMed   Mentions:
    33. Fears and uncertainties of people with Parkinson's disease. J Parkinsons Dis. 2025 May; 15(3):595-602. Trahair ED, Steiger D, Lowe N, Rapoport R, Kelliher C, Benvengo S, Kopil C, Chahine LM, Marras C, Mantri S. PMID: 40179210; PMCID: PMC13347454.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Carriers of LRRK2 pathogenic variants show a milder, anatomically distinct brain signature of Parkinson's disease. medRxiv. 2025 Mar 10. Kopal J, Vo A, Tao Q, Simuni T, Chahine LM, Bzdok D, Dagher A. PMID: 40162258; PMCID: PMC11952604.
      View in: PubMed   Mentions:
    35. Predicting Cerebrospinal Fluid Alpha-Synuclein Seed Amplification Assay Status from Demographics and Clinical Data. medRxiv. 2025 Mar 07. Venuto CS, Herbst K, Chahine LM, Kieburtz K. PMID: 39148857; PMCID: PMC11326325.
      View in: PubMed   Mentions: 1  
    36. LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization. Brain Commun. 2025; 7(2):fcaf103. Chahine LM, Lafontant DE, Choi SH, Iwaki H, Blauwendraat C, Singleton AB, Brumm MC, Alcalay RN, Merchant K, Nudelman KNH, Dagher A, Vo A, Tao Q, Venuto CS, Kieburtz K, Poston KL, Bressman S, Gonzalez-Latapi P, Avants B, Coffey C, Jennings D, Tolosa E, Siderowf A, Marek K, Simuni T, Parkinson’s Progression Markers Initiative . PMID: 40114783; PMCID: PMC11925012.
      View in: PubMed   Mentions: 5  
    37. Nigrostriatal dopaminergic integrity in relation to prefrontal cortex activity and gait performance during dual-task walking in older adults. medRxiv. 2025 Mar 03. Rosso AL, Baillargeon EM, Bohnen NI, Lopresti BJ, Huppert TJ, Chahine LM, Jacobsen E, Rosano C. PMID: 40093203; PMCID: PMC11908329.
      View in: PubMed   Mentions:
    38. Validation of automated detection of REM sleep without atonia using in-laboratory and in-home recordings. J Clin Sleep Med. 2025 03 01; 21(3):583-592. Levendowski DJ, Chahine LM, Lewis SJG, Finstuen TJ, Galbiati A, Berka C, Mosovsky S, Parikh H, Anderson J, Walsh CM, Lee-Iannotti JK, Neylan TC, Strambi LF, Boeve BF, St Louis EK. PMID: 39569509; PMCID: PMC11874090.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    39. Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations. medRxiv. 2025 Jan 20. Akçimen F, Paquette K, Crea PW, Saffie-Awad P, Achoru C, Taiwo F, Ozomma S, Onwuegbuzie G, Khani M, Grant S, Owolabi L, Okereke C, Oshinaike O, Iwuozo E, Lee PS, Oyakhire S, Osemwegie N, Daida K, Abubakar S, Olusanya A, Isayan M, Traurig R, Ogunmodede A, Samuel S, Makarious MB, Sa'ad F, Olanigan R, Levine K, Ogbimi EM, Vitale D, Odiase F, Koretsky MJ, Ojini F, Odeniyi O, Fang ZH, Obianozie N, Hall DA, Nwazor E, Xie T, Nwaokorie F, Padmanaban M, Nwani P, Shamim EA, Nnama A, Standaert D, Komolafe M, Dean M, Osaigbovo G, Disbrow E, Ishola I, Rawls A, Imarhiagbe F, Chandra S, Erameh C, Hinson V, Louie N, Idowu A, Solle J, Norris SA, Ibrahim A, Kilbane C, Sukumar G, Shulman LM, Ezuduemoih D, Staisch J, Breaux S, Dalgard C, Foster ER, Bello A, Ameri A, Real R, Ikwenu E, Morris HR, Anyanwu R, Stimming EF, Billingsley K, Alaofin W, Jerez PA, Agabi O, Hernandez DG, Akinyemi R, Arepalli S, Malik L, Owolabi R, Nyandaiti Y, Leonard HL, Wahab K, Step K, Abiodun O, Hernandez CF, Abdulai F, Iwaki H, Bardien S, Klein C, Hardy J, Houlden H, Galvelis KG, Nalls MA, Dahodwala N, Aamodt W, Hill E, Espay A, Factor S, Branson C, Blauwendraat C, Singleton AB, Ojo O, Chahine LM, Black and African American Connections to Parkinson’s Disease Study (BLAAC PD), Nigeria Parkinson’s Disease Research Network (NPDRN), Racial Disparities in Parkinson Disease (RaD-PD), Global Parkinson’s Genetics Program (GP2), Okubadejo N, Bandres-Ciga S. PMID: 39867380; PMCID: PMC11759243.
      View in: PubMed   Mentions:
    40. Effects of 6 months of endurance exercise on motor function, exercise capacity, and autonomic function based on presence of autonomic dysfunction in individuals with early Parkinson's disease. J Parkinsons Dis. 2025 Mar; 15(2):387-396. Griffith GJ, Mehta N, Lamotte G, McKee KE, Suttman E, Haus JM, Joslin E, Balfany K, Kohrt WM, Christiansen CL, Melanson EL, Chahine LM, Christou DD, Patterson CG, Corcos DM. PMID: 39973503; PMCID: PMC13347429.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. Concordance and test-retest consistency of sleep biomarker-based neurodegenerative disorder profiling. Sci Rep. 2024 12 28; 14(1):31234. Levendowski DJ, Tsuang D, Chahine LM, Walsh CM, Berka C, Lee-Iannotti JK, Salat D, Fischer C, Mazeika G, Boeve BF, Strambi LF, Lewis SJG, Neylan TC, St Louis EK. PMID: 39732824; PMCID: PMC11682374.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    42. Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease. Ann Neurol. 2025 04; 97(4):730-740. Brown EG, Chahine LM, Siderowf A, Gochanour C, Kurth R, Marshall MJ, Caspell-Garcia C, Brumm MC, Stanley CE, Korell M, McMahon B, Kuhl M, Fabrizio K, Heathers L, Concha-Marambio L, Soto C, Chowdhury S, Coffey CS, Foroud TM, Simuni T, Marek K, Tanner CM, Parkinson Progression Marker Initiative. PMID: 39719857; PMCID: PMC11889527.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    43. Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia. medRxiv. 2024 Dec 13. Weintraub D, Nair AR, Kurth R, Brumm MC, York MK, Dobkin R, Marek K, Tanner C, Simuni T, Siderowf A, Galasko D, Chahine LM, Coffey C, Merchant K, Poston KL, Foroud T, Mollenhauer B, Brown EG, Kieburtz K, Frasier M, Sherer T, Chowdhury S, Alcalay RN, Videnovic A, Parkinson’s Progression Markers Initiative. PMID: 39711699; PMCID: PMC11661337.
      View in: PubMed   Mentions:
    44. Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications. Mov Disord. 2025 Feb; 40(2):204-221. Atterling Brolin K, Schaeffer E, Kuri A, Rumrich IK, Schumacher Schuh AF, Darweesh SKL, Kaasinen V, Tolppanen AM, Chahine LM, Noyce AJ. PMID: 39601461; PMCID: PMC11832802.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansPHPublic Health
    45. What Parkinson's disease patients say in their own words about their mood and anxiety symptoms. Parkinsonism Relat Disord. 2025 Jan; 130:107190. Anderson KE, Marras C, Amara A, Chahine LM, Eberly S, Hosamath A, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Weintraub D, Shoulson I, Arbatti L. PMID: 39579746.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. REM Sleep Behavior Disorder Diagnostic Code Accuracy and Implications in the Real-World Setting. Neurol Clin Pract. 2025 Feb; 15(1):e200387. Chahine LM, Ratner D, Palmquist A, Dholakia G, Newman AB, Boyce RD, Rosano C, Brooks M. PMID: 39524103; PMCID: PMC11547835.
      View in: PubMed   Mentions:
    47. Higher Striatal Dopamine is Related With Lower Physical Performance Fatigability in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2024 11 01; 79(11). Rosano C, Chahine LM, Gay EL, Coen PM, Bohnen NI, Studenski SA, LoPresti B, Rosso AL, Huppert T, Newman AB, Royse SK, Kritchevsky SB, Glynn NW. PMID: 39208421; PMCID: PMC11447735.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    48. The Black and African American Connections to Parkinson's Disease (BLAAC PD) study protocol. BMC Neurol. 2024 Oct 21; 24(1):403. Chahine LM, Louie N, Solle J, Akçimen F, Ameri A, Augenbraun S, Avripas S, Breaux S, Causey C, Chandra S, Dean M, Disbrow EA, Fanty L, Fernandez J, Foster ER, Furr Stimming E, Hall D, Hinson V, Johnson-Turbes A, Jonas C, Kilbane C, Norris SA, Nguyen BT, Padmanaban M, Paquette K, Parry C, Pessoa Rocha N, Rawls A, Shamim EA, Shulman LM, Sipma R, Staisch J, Traurig R, von Coelln R, Wild Crea P, Xie T, Fang ZH, O'Grady A, Kopil CM, McGuire Kuhl M, Singleton A, Blauwendraat C, Bandres-Ciga S, BLAAC PD Study and the Global Parkinson’s Genetics Program (GP2). PMID: 39434044; PMCID: PMC11492614.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    49. Eleven Years of Change: Disease Progression in Biomarker-Defined Sporadic Parkinson's Disease. medRxiv. 2024 Oct 10. Gonzalez-Latapi P, Gochanour C, Cho H, Ho Choi S, Caspell-Garcia C, Coffey C, Brumm M, Lafontant DE, Xiao Y, Tanner C, Venuto CS, Kieburtz K, Chahine LM, Poston KL, Siderowf A, Marek K, Simuni T. PMID: 39417131; PMCID: PMC11482996.
      View in: PubMed   Mentions:
    50. Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts. NPJ Parkinsons Dis. 2024 Sep 27; 10(1):178. Dam T, Pagano G, Brumm MC, Gochanour C, Poston KL, Weintraub D, Chahine LM, Coffey C, Tanner CM, Kopil CM, Xiao Y, Chowdhury S, Concha-Marambio L, DiBiaso P, Foroud T, Frasier M, Jennings D, Kieburtz K, Merchant K, Mollenhauer B, Montine TJ, Nudelman K, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tolosa E, Siderowf A, Dunn B, Simuni T, Marek K, Parkinson’s Progression Markers Initiative. PMID: 39333167; PMCID: PMC11567150.
      View in: PubMed   Mentions: 12  
    51. Neuronal alpha-Synuclein Disease Integrated Staging System performance in PPMI, PASADENA, and SPARK baseline cohorts. medRxiv. 2024 Sep 10. Dam T, Pagano G, Brumm MC, Gochanour C, Poston KL, Weintraub D, Chahine LM, Coffey C, Tanner CM, Kopil CM, Xiao Y, Chowdhury S, Concha-Marambio L, DiBiaso P, Foroud T, Frasier M, Jennings D, Kieburtz K, Merchant K, Mollenhauer B, Montine TJ, Nudelman K, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tolosa E, Siderowf A, Dunn B, Simuni T, Marek K, Parkinson’s Progression Markers Initiative. PMID: 39314957; PMCID: PMC11419206.
      View in: PubMed   Mentions:
    52. Long-Term Dementia Risk in Parkinson Disease. Neurology. 2024 09 10; 103(5):e209699. Gallagher J, Gochanour C, Caspell-Garcia C, Dobkin RD, Aarsland D, Alcalay RN, Barrett MJ, Chahine L, Chen-Plotkin AS, Coffey CS, Dahodwala N, Eberling JL, Espay AJ, Leverenz JB, Litvan I, Mamikonyan E, Morley J, Richard IH, Rosenthal L, Siderowf AD, Simuni T, York MK, Willis AW, Xie SX, Weintraub D, Parkinson's Progression Markers Initiative. PMID: 39110916; PMCID: PMC11318527.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    53. LRRK2-Associated Parkinsonism With and Without In Vivo Evidence of Alpha-Synuclein Aggregates. medRxiv. 2024 Jul 22. Chahine LM, Lafontant DE, Ho Choi S, Iwaki H, Blauwendraat C, Singleton AB, Brumm MC, Alcalay RN, Merchant K, Nudelman KNH, Dagher A, Vo A, Tao Q, Venuto CS, Kieburtz K, Poston KL, Bressman S, Gonzalez-Latapi P, Avants B, Coffey C, Jennings D, Tolosa E, Siderowf A, Marek K, Simuni T. PMID: 39108519; PMCID: PMC11302724.
      View in: PubMed   Mentions:
    54. Cognitive Symptoms in Cross-Sectional Parkinson Disease Cohort Evaluated by Human-in-the-Loop Machine Learning and Natural Language Processing. Neurol Clin Pract. 2024 Oct; 14(5):e200334. Purks JL, Arbatti L, Hosamath A, Amara AW, Anderson KE, Chahine L, Eberly SW, Kinel D, Mantri S, Mathur S, Oakes D, Standaert DG, Weintraub D, Shoulson I, Marras C. PMID: 38962394; PMCID: PMC11221914.
      View in: PubMed   Mentions: 4  
    55. Concerns with the new biological research criteria for synucleinopathy - Authors' reply. Lancet Neurol. 2024 07; 23(7):663-666. Simuni T, Chahine LM, Weintraub D, Poston KM, Kopil CM, Dunn B, Marek K. PMID: 38876741.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    56. Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease. Mov Disord. 2024 Apr; 39(4):706-714. Weintraub D, Marras C, Amara A, Anderson KE, Chahine LM, Eberly S, Hosamath A, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Shoulson I, Arbatti L. PMID: 38318953.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    57. A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 2024 02; 23(2):178-190. Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, Kieburtz K, Kopil CM, Merchant K, Mollenhauer B, Montine T, Nudelman K, Pagano G, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tanner CM, Tolosa E, Weintraub D, Xiao Y, Siderowf A, Dunn B, Marek K. PMID: 38267190.
      View in: PubMed   Mentions: 288     Fields:    Translation:HumansCells
    58. Chronotropic Incompetence During Exercise Testing as a Marker of Autonomic Dysfunction in Individuals with Early Parkinson's Disease. J Parkinsons Dis. 2024; 14(1):121-133. Griffith G, Lamotte G, Mehta N, Fan P, Nikolich J, Springman V, Suttman E, Joslin E, Balfany K, Dunlap M, Kohrt WM, Christiansen CL, Melanson EL, Josbeno D, Chahine LM, Patterson CG, Corcos DM. PMID: 38189712; PMCID: PMC10836543.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    59. In Their Own Words: Fears Expressed by People with Parkinson's Disease in an Online Symptom Database. J Parkinsons Dis. 2024; 14(4):865-872. Mantri S, Purks JL, Kinel D, Arbatti L, Hosamath A, Allen A, Amara A, Anderson K, Chahine LM, Eberly S, Mathur S, Standaert D, Oakes D, Weintraub D, Shoulson I, Marras C. PMID: 38669556; PMCID: PMC11191490.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    60. Internal tremor in people with Parkinson's Disease: Demographic characteristics and comorbid symptoms. Clin Park Relat Disord. 2023; 9:100229. Chahine LM, Arbatti L, Hosamath A, Amara A, Anderson KE, Purks J, Eberly S, Kinel D, Mantri S, Mathur S, Oakes D, Standaert DG, Weintraub D, Shoulson I, Marras C. PMID: 38045566; PMCID: PMC10689282.
      View in: PubMed   Mentions:
    61. Physical Activity and the Risk of Parkinson Disease: Moving in the Right Direction. Neurology. 2023 07 25; 101(4):151-152. Chahine LM, Darweesh SKL. PMID: 37197992.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. Course of Impulse Control Disorder Symptoms in Parkinson's Disease: Deep Brain Stimulation Versus Medications. Mov Disord Clin Pract. 2023 Jun; 10(6):903-913. Hernandez-Con P, Lin I, Mamikonyan E, Deeb W, Feldman R, Althouse A, Barmore R, Eisinger RS, Spindler M, Okun MS, Weintraub D, Chahine LM. PMID: 37332637; PMCID: PMC10272921.
      View in: PubMed   Mentions: 6     Fields:    
    63. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 2023 05; 22(5):407-417. Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, Tanner CM, Weintraub D, Videnovic A, Choi SH, Kurth R, Caspell-Garcia C, Coffey CS, Frasier M, Oliveira LMA, Hutten SJ, Sherer T, Marek K, Soto C, Parkinson's Progression Markers Initiative. PMID: 37059509; PMCID: PMC10627170.
      View in: PubMed   Mentions: 316     Fields:    Translation:Humans
    64. Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study. Mov Disord Clin Pract. 2023 Jun; 10(6):943-955. Weintraub D, Picillo M, Cho HR, Caspell-Garcia C, Blauwendraat C, Brown EG, Chahine LM, Coffey CS, Dobkin RD, Foroud T, Galasko D, Kieburtz K, Marek K, Merchant K, Mollenhauer B, Poston KL, Simuni T, Siderowf A, Singleton A, Seibyl J, Tanner CM, Parkinson's Progression Markers Initiative. PMID: 37332638; PMCID: PMC10272925.
      View in: PubMed   Mentions: 3     Fields:    
    65. International Consensus Statement on Obstructive Sleep Apnea. Int Forum Allergy Rhinol. 2023 07; 13(7):1061-1482. Chang JL, Goldberg AN, Alt JA, Mohammed A, Ashbrook L, Auckley D, Ayappa I, Bakhtiar H, Barrera JE, Bartley BL, Billings ME, Boon MS, Bosschieter P, Braverman I, Brodie K, Cabrera-Muffly C, Caesar R, Cahali MB, Cai Y, Cao M, Capasso R, Caples SM, Chahine LM, Chang CP, Chang KW, Chaudhary N, Cheong CSJ, Chowdhuri S, Cistulli PA, Claman D, Collen J, Coughlin KC, Creamer J, Davis EM, Dupuy-McCauley KL, Durr ML, Dutt M, Ali ME, Elkassabany NM, Epstein LJ, Fiala JA, Freedman N, Gill K, Gillespie MB, Golisch L, Gooneratne N, Gottlieb DJ, Green KK, Gulati A, Gurubhagavatula I, Hayward N, Hoff PT, Hoffmann OMG, Holfinger SJ, Hsia J, Huntley C, Huoh KC, Huyett P, Inala S, Ishman SL, Jella TK, Jobanputra AM, Johnson AP, Junna MR, Kado JT, Kaffenberger TM, Kapur VK, Kezirian EJ, Khan M, Kirsch DB, Kominsky A, Kryger M, Krystal AD, Kushida CA, Kuzniar TJ, Lam DJ, Lettieri CJ, Lim DC, Lin HC, Liu SYC, MacKay SG, Magalang UJ, Malhotra A, Mansukhani MP, Maurer JT, May AM, Mitchell RB, Mokhlesi B, Mullins AE, Nada EM, Naik S, Nokes B, Olson MD, Pack AI, Pang EB, Pang KP, Patil SP, Van de Perck E, Piccirillo JF, Pien GW, Piper AJ, Plawecki A, Quigg M, Ravesloot MJL, Redline S, Rotenberg BW, Ryden A, Sarmiento KF, Sbeih F, Schell AE, Schmickl CN, Schotland HM, Schwab RJ, Seo J, Shah N, Shelgikar AV, Shochat I, Soose RJ, Steele TO, Stephens E, Stepnowsky C, Strohl KP, Sutherland K, Suurna MV, Thaler E, Thapa S, Vanderveken OM, de Vries N, Weaver EM, Weir ID, Wolfe LF, Woodson BT, Won CHJ, Xu J, Yalamanchi P, Yaremchuk K, Yeghiazarians Y, Yu JL, Zeidler M, Rosen IM. PMID: 36068685; PMCID: PMC10359192.
      View in: PubMed   Mentions: 146     Fields:    Translation:Humans
    66. Central and peripheral α-synuclein in Parkinson disease detected by seed amplification assay. Ann Clin Transl Neurol. 2023 05; 10(5):696-705. Chahine LM, Beach TG, Adler CH, Hepker M, Kanthasamy A, Appel S, Pritzkow S, Pinho M, Mosovsky S, Serrano GE, Coffey C, Brumm MC, Oliveira LMA, Eberling J, Mollenhauer B, Systemic Synuclein Sampling Study. PMID: 36972727; PMCID: PMC10187727.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    67. LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts. NPJ Parkinsons Dis. 2023 Feb 28; 9(1):30. Merchant KM, Simuni T, Fedler J, Caspell-Garcia C, Brumm M, Nudelman KNH, Tengstrandt E, Hsieh F, Alcalay RN, Coffey C, Chahine L, Foroud T, Singleton A, Weintraub D, Hutten S, Sherer T, Mollenhauer B, Siderowf A, Tanner C, Marek K, the Parkinson’s Progression Markers Initiative. PMID: 36854767; PMCID: PMC9974978.
      View in: PubMed   Mentions: 15  
    68. Role of novel endpoints and evaluations of response in Parkinson disease. Handb Clin Neurol. 2023; 193:325-345. Chahine LM, Simuni T. PMID: 36803820.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    69. What Patients Say: Large-Scale Analyses of Replies to the Parkinson's Disease Patient Report of Problems (PD-PROP). J Parkinsons Dis. 2023; 13(5):757-767. Marras C, Arbatti L, Hosamath A, Amara A, Anderson KE, Chahine LM, Eberly S, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Tanner CM, Weintraub D, Shoulson I. PMID: 37334615; PMCID: PMC10473108.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    70. Proposal for a Biologic Staging System of Parkinson's Disease. J Parkinsons Dis. 2023; 13(3):297-309. Chahine LM, Merchant K, Siderowf A, Sherer T, Tanner C, Marek K, Simuni T. PMID: 37066922; PMCID: PMC10200239.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    71. Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression. J Parkinsons Dis. 2023; 13(6):899-916. Brumm MC, Siderowf A, Simuni T, Burghardt E, Choi SH, Caspell-Garcia C, Chahine LM, Mollenhauer B, Foroud T, Galasko D, Merchant K, Arnedo V, Hutten SJ, O'Grady AN, Poston KL, Tanner CM, Weintraub D, Kieburtz K, Marek K, Coffey CS, Parkinson’s Progression Markers Initiative. PMID: 37458046; PMCID: PMC10578214.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    72. Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort. NPJ Parkinsons Dis. 2022 Oct 22; 8(1):140. Simuni T, Merchant K, Brumm MC, Cho H, Caspell-Garcia C, Coffey CS, Chahine LM, Alcalay RN, Nudelman K, Foroud T, Mollenhauer B, Siderowf A, Tanner C, Iwaki H, Sherer T, Marek K, Parkinson’s Progression Marker Initiative Authors. PMID: 36273008; PMCID: PMC9588016.
      View in: PubMed   Mentions: 7  
    73. Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial. Trials. 2022 Oct 06; 23(1):855. Patterson CG, Joslin E, Gil AB, Spigle W, Nemet T, Chahine L, Christiansen CL, Melanson E, Kohrt WM, Mancini M, Josbeno D, Balfany K, Griffith G, Dunlap MK, Lamotte G, Suttman E, Larson D, Branson C, McKee KE, Goelz L, Poon C, Tilley B, Kang UJ, Tansey MG, Luthra N, Tanner CM, Haus JM, Fantuzzi G, McFarland NR, Gonzalez-Latapi P, Foroud T, Motl R, Schwarzschild MA, Simuni T, Marek K, Naito A, Lungu C, Corcos DM, SPARX3-PSG Investigators. PMID: 36203214; PMCID: PMC9535216.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    74. Prodromal α-Synucleinopathies. Continuum (Minneap Minn). 2022 Oct 01; 28(5):1268-1280. Chahine LM. PMID: 36222764.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    75. Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson's disease. Clin Auton Res. 2022 12; 32(6):463-476. Miller-Patterson C, Hsu JY, Chahine LM, Morley JF, Willis AW. PMID: 36057046; PMCID: PMC10979289.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    76. Outcome Assessment in Parkinson Disease Prevention Trials: Utility of Clinical and Digital Measures. Neurology. 2022 08 16; 99(7 Suppl 1):52-60. Mirelman A, Siderowf A, Chahine L. PMID: 35970590.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    77. Early Autonomic Symptoms Predict Functional Decline in Parkinson's Disease Independent of Dopaminergic Therapy. Neurodegener Dis. 2022; 22(1):15-23. Miller-Patterson C, Hsu JY, Chahine LM. PMID: 35785765; PMCID: PMC9671814.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    78. Mild Parkinsonian Signs, Energy Decline, and Striatal Volume in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2022 04 01; 77(4):800-806. Tian Q, Ehrenkranz R, Rosso AL, Glynn NW, Chahine LM, Hengenius J, Zhu X, Rosano C. PMID: 34049395; PMCID: PMC8974349.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    79. Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence. Acta Neuropathol Commun. 2022 02 14; 10(1):21. Signaevsky M, Marami B, Prastawa M, Tabish N, Iida MA, Zhang XF, Sawyer M, Duran I, Koenigsberg DG, Bryce CH, Chahine LM, Mollenhauer B, Mosovsky S, Riley L, Dave KD, Eberling J, Coffey CS, Adler CH, Serrano GE, White CL, Koll J, Fernandez G, Zeineh J, Cordon-Cardo C, Beach TG, Crary JF. PMID: 35164870; PMCID: PMC8842941.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    80. Surveying Global Availability of Parkinson's Disease Treatment. J Parkinsons Dis. 2022; 12(3):1023-1034. Goh ZHK, Cheong JLY, Marras C, Tanner CM, Kasten M, Korczyn AD, Chahine L, Lo R, Noyce AJ, Movement Disorders Society Epidemiology Study Group. PMID: 35147549.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    81. Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's Disease. Mov Disord Clin Pract. 2022 Jan; 9(1):76-81. Mantri S, Chahine LM, Nabieva K, Feldman R, Althouse A, Torsney B, Albert SM, Kopil C, Marras C. PMID: 35005068; PMCID: PMC8721823.
      View in: PubMed   Mentions: 6     Fields:    
    82. Diffusion Tensor Imaging of the Olfactory System in Older Adults With and Without Hyposmia. Front Aging Neurosci. 2021; 13:648598. Felix C, Chahine LM, Hengenius J, Chen H, Rosso AL, Zhu X, Cao Z, Rosano C. PMID: 34744681; PMCID: PMC8569942.
      View in: PubMed   Mentions: 9  
    83. Use of Figurative Language by People With Parkinson Disease to Describe "Off" Periods: Clear as Mud. Neurol Clin Pract. 2021 Aug; 11(4):e462-e471. Chahine LM, Edison B, Daeschler M, Siddiqi B, Kopil C, Marras C, Mantri S. PMID: 34476127; PMCID: PMC8382437.
      View in: PubMed   Mentions: 6  
    84. Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning. Lancet Digit Health. 2021 09; 3(9):e555-e564. Severson KA, Chahine LM, Smolensky LA, Dhuliawala M, Frasier M, Ng K, Ghosh S, Hu J. PMID: 34334334.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    85. The Experience of OFF Periods in Parkinson's Disease: Descriptions, Triggers, and Alleviating Factors. J Patient Cent Res Rev. 2021; 8(3):232-238. Mantri S, Lepore M, Edison B, Daeschler M, Kopil CM, Marras C, Chahine LM. PMID: 34322575; PMCID: PMC8297496.
      View in: PubMed   Mentions: 13  
    86. Author Response: In Vivo Distribution of α-Synuclein in Multiple Tissues and Biofluids in Parkinson Disease. Neurology. 2021 05 18; 96(20):965-967. Beach T, Chahine LM, Adler CH, Mollenhauer B. PMID: 34001544.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    87. Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease. Mov Disord. 2021 08; 36(8):1972-1978. Kremer T, Taylor KI, Siebourg-Polster J, Gerken T, Staempfli A, Czech C, Dukart J, Galasko D, Foroud T, Chahine LM, Coffey CS, Simuni T, Weintraub D, Seibyl J, Poston KL, Toga AW, Tanner CM, Marek K, Hutten SJ, Dziadek S, Trenkwalder C, Pagano G, Mollenhauer B. PMID: 33942926; PMCID: PMC8453505.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    88. The experience of care partners of patients with Parkinson's disease psychosis. PLoS One. 2021; 16(3):e0248968. Mantri S, Klawson E, Albert S, Rapoport R, Precht C, Glancey S, Daeschler M, Mamikonyan E, Kopil CM, Marras C, Chahine LM. PMID: 33740031; PMCID: PMC7978339.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    89. Changes in Self-Reported Energy Levels in Prodromal Parkinson's Disease. Mov Disord. 2021 05; 36(5):1276-1277. Chahine LM, Zhu X, Ehrenkranz R, Chen H, Glynn NW, Rosano C. PMID: 33634907; PMCID: PMC8840801.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    90. Contribution of neuropsychiatric symptoms in Parkinson's disease to different domains of caregiver burden. J Neurol. 2021 Aug; 268(8):2961-2972. Chahine LM, Feldman R, Althouse A, Torsney B, Alzyoud L, Mantri S, Edison B, Albert S, Daeschler M, Kopil C, Marras C. PMID: 33629181; PMCID: PMC8289810.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    91. Triggers and alleviating factors for fatigue in Parkinson's disease. PLoS One. 2021; 16(2):e0245285. Lin I, Edison B, Mantri S, Albert S, Daeschler M, Kopil C, Marras C, Chahine LM. PMID: 33540422; PMCID: PMC7861907.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    92. Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease Psychosis. Front Neurol. 2021; 12:633645. Mantri S, Edison B, Alzyoud L, Albert SM, Daeschler M, Kopil C, Marras C, Chahine LM. PMID: 33597918; PMCID: PMC7882678.
      View in: PubMed   Mentions: 5  
    93. Toward e-Scales: Digital Administration of the International Parkinson and Movement Disorder Society Rating Scales. Mov Disord Clin Pract. 2021 Feb; 8(2):208-214. Monje MHG, Fuller RLM, Cubo E, Mestre TA, Tan AH, Stout JC, Ali S, Chahine L, Dujardin K, Fitzer-Attas CJ, Youn J, Bloem BR, Horak FB, Merola A, Reilmann R, Paul SS, Dorsey ER, Maetzler W, Espay AJ, Martinez-Martin P, Stebbins GT, Sánchez-Ferro Á, MDS Rating Scales Program Electronic Development Committee and the MDS Technology Taskforce. PMID: 33553489; PMCID: PMC7853197.
      View in: PubMed   Mentions: 2     Fields:    
    94. Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder. Ann Clin Transl Neurol. 2021 01; 8(1):201-212. Chahine LM, Brumm MC, Caspell-Garcia C, Oertel W, Mollenhauer B, Amara A, Fernandez-Arcos A, Tolosa E, Simonet C, Hogl B, Videnovic A, Hutten SJ, Tanner C, Weintraub D, Burghardt E, Coffey C, Cho HR, Kieburtz K, Poston KL, Merchant K, Galasko D, Foroud T, Siderowf A, Marek K, Simuni T, Iranzo A. PMID: 33321002; PMCID: PMC7818144.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    95. Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients. Ann Clin Transl Neurol. 2020 10; 7(10):1816-1830. Alcalay RN, Wolf P, Chiang MSR, Helesicova K, Zhang XK, Merchant K, Hutten SJ, Scherzer C, Caspell-Garcia C, Blauwendraat C, Foroud T, Nudelman K, Gan-Or Z, Simuni T, Chahine LM, Levy O, Zheng D, Li G, Sardi SP, Parkinson’s Progression Markers Initiative. PMID: 32888397; PMCID: PMC7545591.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    96. Sleep and circadian rhythms in the treatment, trajectory, and prevention of neurodegenerative disease. Neurobiol Dis. 2020 11; 145:105075. Wilckens KA, Chahine LM. PMID: 32890772.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's Disease. Mov Disord Clin Pract. 2020 Oct; 7(7):879-880. Chahine LM, Edison B, Mantri S, Kopil C, Marras C. PMID: 33043094; PMCID: PMC7533975.
      View in: PubMed   Mentions:    Fields:    
    98. Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression. Mov Disord. 2020 11; 35(11):1999-2008. Mollenhauer B, Dakna M, Kruse N, Galasko D, Foroud T, Zetterberg H, Schade S, Gera RG, Wang W, Gao F, Frasier M, Chahine LM, Coffey CS, Singleton AB, Simuni T, Weintraub D, Seibyl J, Toga AW, Tanner CM, Kieburtz K, Marek K, Siderowf A, Cedarbaum JM, Hutten SJ, Trenkwalder C, Graham D. PMID: 32798333; PMCID: PMC8017468.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansCells
    99. In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease. Neurology. 2020 09 01; 95(9):e1267-e1284. Chahine LM, Beach TG, Brumm MC, Adler CH, Coffey CS, Mosovsky S, Caspell-Garcia C, Serrano GE, Munoz DG, White CL, Crary JF, Jennings D, Taylor P, Foroud T, Arnedo V, Kopil CM, Riley L, Dave KD, Mollenhauer B, Systemic Synuclein Sampling Study. PMID: 32747521; PMCID: PMC7538226.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    100. Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease. Ann Neurol. 2020 09; 88(3):574-587. Irwin DJ, Fedler J, Coffey CS, Caspell-Garcia C, Kang JH, Simuni T, Foroud T, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Weintraub D, Mollenhauer B, Galasko DR, Siderowf A, Marek K, Trojanowski JQ, Shaw LM, Parkinson's Progression Marker Initiative. PMID: 32542885; PMCID: PMC7497251.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    101. Sex Disparities in Autonomic Symptom Treatment in Parkinson's Disease. Mov Disord Clin Pract. 2020 Aug; 7(6):718-719. Miller-Patterson C, Edwards KA, Chahine LM. PMID: 32775527; PMCID: PMC7396847.
      View in: PubMed   Mentions: 4     Fields:    
    102. Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine? Mov Disord. 2020 09; 35(9):1618-1625. Purri R, Brennan L, Rick J, Xie SX, Deck BL, Chahine LM, Dahodwala N, Chen-Plotkin A, Duda JE, Morley JF, Akhtar RS, Trojanowski JQ, Siderowf A, Weintraub D. PMID: 32520435; PMCID: PMC7722141.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    103. Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease. Ann Clin Transl Neurol. 2020 04; 7(4):449-461. Weintraub D, Caspell-Garcia C, Simuni T, Cho HR, Coffey CS, Aarsland D, Alcalay RN, Barrett MJ, Chahine LM, Eberling J, Espay AJ, Hamilton J, Hawkins KA, Leverenz J, Litvan I, Richard I, Rosenthal LS, Siderowf A, York M, Parkinson’s Progression Markers Initiative. PMID: 32285645; PMCID: PMC7187707.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    104. Parkinson's disease in the MENASA countries. Lancet Neurol. 2020 04; 19(4):293-294. Khalil H, Chahine L, Siddiqui J, Aldaajani Z, Bajwa JA. PMID: 32169157.
      View in: PubMed   Mentions: 13     Fields:    
    105. The Most Bothersome Aspects of Off Periods Reported by Individuals with Parkinson's Disease. Mov Disord Clin Pract. 2020 Apr; 7(3):284-292. Chahine LM, Edison B, Daeschler M, Mantri S, Kahl S, Rapoport R, Goyle A, Precht C, Kopil C, Marras C. PMID: 32258226; PMCID: PMC7111578.
      View in: PubMed   Mentions: 11     Fields:    
    106. Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study. Mov Disord. 2020 05; 35(5):833-844. Simuni T, Brumm MC, Uribe L, Caspell-Garcia C, Coffey CS, Siderowf A, Alcalay RN, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Nudelman K, Tosun-Turgut D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Bressman S, Marek K, Parkinson's Progression Markers Initiative Investigators. PMID: 32073681; PMCID: PMC7231646.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    107. Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience. J Parkinsons Dis. 2020; 10(2):665-675. Dobkin RD, Amondikar N, Kopil C, Caspell-Garcia C, Brown E, Chahine LM, Marras C, Dahodwala N, Mantri S, Standaert DG, Dean M, Shoulson I, Marek K, Katz A, Korell M, Riley L, Tanner CM, Fox Insight Study. PMID: 32250321; PMCID: PMC7242847.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    108. The Effect of the COVID-19 Pandemic on People with Parkinson's Disease. J Parkinsons Dis. 2020; 10(4):1365-1377. Brown EG, Chahine LM, Goldman SM, Korell M, Mann E, Kinel DR, Arnedo V, Marek KL, Tanner CM. PMID: 32925107; PMCID: PMC7683050.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansPHPublic Health
    109. Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person. J Parkinsons Dis. 2020; 10(2):677-691. Chahine LM, Chin I, Caspell-Garcia C, Standaert DG, Brown E, Smolensky L, Arnedo V, Daeschler D, Riley L, Korell M, Dobkin R, Amondikar N, Gradinscak S, Shoulson I, Dean M, Kwok K, Cannon P, Marek K, Kopil C, Tanner CM, Marras C, Fox Insight Study. PMID: 31958097; PMCID: PMC7242834.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    110. Parkinson's Disease in the Middle East, North Africa, and South Asia: Consensus from the International Parkinson and Movement Disorder Society Task Force for the Middle East. J Parkinsons Dis. 2020; 10(2):729-741. Khalil H, Chahine LM, Siddiqui J, Salari M, El-Jaafary S, Aldaajani Z, Abu Al-Melh M, Mohammad TM, Abu Snineh M, Syed NA, Bhatt M, Habib MA, Habahbeh M, Tabbal SD, Jeon B, Bajwa JA. PMID: 32176653; PMCID: PMC8203232.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    111. Understanding the Lexicon of Fatigue in Parkinson's Disease. J Parkinsons Dis. 2020; 10(3):1185-1193. Mantri S, Klawson E, Albert S, Nabieva K, Lepore M, Kahl S, Daeschler M, Mamikonyan E, Kopil C, Marras C, Chahine LM. PMID: 32568110; PMCID: PMC7458521.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    112. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study. Lancet Neurol. 2020 01; 19(1):71-80. Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten SJ, Bressman S, Marek K, PPMI Investigators. PMID: 31678032; PMCID: PMC6956652.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    113. Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease. Mov Disord. 2019 09; 34(9):1354-1364. Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Singleton A, Shaw LM, Trojanowski JQ, Frasier M, Simuni T, Iranzo A, Oertel W, Siderowf A, Weintraub D, Seibyl J, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Marek K, Galasko D, PPMI study. PMID: 31361367; PMCID: PMC7098385.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    114. Regional Gray Matter Volume Links Rest-Activity Rhythm Fragmentation With Past Cognitive Decline. Am J Geriatr Psychiatry. 2020 02; 28(2):248-251. Smagula SF, Chahine L, Metti A, Rangarajan A, Aizenstein HJ, Tian Q, Rosano C. PMID: 31377045; PMCID: PMC6980463.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    115. Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progression. NPJ Parkinsons Dis. 2019; 5:7. Pereira JB, Weintraub D, Chahine L, Aarsland D, Hansson O, Westman E. PMID: 31069252; PMCID: PMC6499806.
      View in: PubMed   Mentions: 31  
    116. Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI). Parkinsonism Relat Disord. 2019 05; 62:201-209. Prakash N, Caspell-Garcia C, Coffey C, Siderowf A, Tanner CM, Kieburtz K, Mollenhauer B, Galasko D, Merchant K, Foroud T, Chahine LM, Weintraub D, Casaceli C, Dorsey R, Wilson R, Herzog M, Daegele N, Arnedo V, Frasier M, Sherer T, Marek K, Frank S, Jennings D, Simuni T, Parkinson's Progression Markers InitiativeSteering Committee, Study Cores, Site Investigators, Coordinators, Industry and Scientific Advisory Board. PMID: 30738748; PMCID: PMC8978879.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    117. Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder. NPJ Parkinsons Dis. 2019; 5:2. Chahine LM, Iranzo A, Fernández-Arcos A, Simuni T, Seedorff N, Caspell-Garcia C, Amara AW, Comella C, Högl B, Hamilton J, Marek K, Mayer G, Mollenhauer B, Postuma R, Tolosa E, Trenkwalder C, Videnovic A, Oertel W, PPMI Sleep Working Group. PMID: 30701189; PMCID: PMC6351563.
      View in: PubMed   Mentions: 16  
    118. Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures. J Parkinsons Dis. 2019; 9(4):665-679. Chahine LM, Siderowf A, Barnes J, Seedorff N, Caspell-Garcia C, Simuni T, Coffey CS, Galasko D, Mollenhauer B, Arnedo V, Daegele N, Frasier M, Tanner C, Kieburtz K, Marek K, The Parkinson’s Progression Markers Initiative. PMID: 31450510; PMCID: PMC6839498.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    119. Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter Imaging. J Parkinsons Dis. 2019; 9(2):327-334. Massa J, Chahine LM. PMID: 30958313.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    120. Self-reported physical activity levels and clinical progression in early Parkinson's disease. Parkinsonism Relat Disord. 2019 04; 61:118-125. Amara AW, Chahine L, Seedorff N, Caspell-Garcia CJ, Coffey C, Simuni T, Parkinson's Progression Markers Initiative. PMID: 30554993.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    121. The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort. Ann Clin Transl Neurol. 2018 Dec; 5(12):1460-1477. Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun-Turgut D, Poston K, Arnedo V, Frasier M, Sherer T, Parkinson's Progression Markers Initiative. PMID: 30564614; PMCID: PMC6292383.
      View in: PubMed   Mentions: 315     Fields:    
    122. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease. Eur J Neurol. 2019 02; 26(2):246-e18. Chahine LM, Dos Santos C, Fullard M, Scordia C, Weintraub D, Erus G, Rosenthal L, Davatzikos C, McMillan CT. PMID: 30169897; PMCID: PMC6329649.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    123. Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4). J Neuropathol Exp Neurol. 2018 09 01; 77(9):793-802. Beach TG, Serrano GE, Kremer T, Canamero M, Dziadek S, Sade H, Derkinderen P, Corbillé AG, Letournel F, Munoz DG, White CL, Schneider J, Crary JF, Sue LI, Adler CH, Glass MJ, Intorcia AJ, Walker JE, Foroud T, Coffey CS, Ecklund D, Riss H, Goßmann J, König F, Kopil CM, Arnedo V, Riley L, Linder C, Dave KD, Jennings D, Seibyl J, Mollenhauer B, Chahine L, Systemic Synuclein Sampling Study (S4). PMID: 30107604; PMCID: PMC6097838.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    124. Cognition among individuals along a spectrum of increased risk for Parkinson's disease. PLoS One. 2018; 13(8):e0201964. Chahine LM, Urbe L, Caspell-Garcia C, Aarsland D, Alcalay R, Barone P, Burn D, Espay AJ, Hamilton JL, Hawkins KA, Lasch S, Leverenz JB, Litvan I, Richard I, Siderowf A, Coffey CS, Simuni T, Weintraub D, Parkinson’s Progression Markers Initiative. PMID: 30125297; PMCID: PMC6101368.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    125. Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort. Mov Disord. 2018 05; 33(5):771-782. Simuni T, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun D, Poston K, Arnedo V, Frasier M, Sherer T, Chowdhury S, Marek K, Parkinson's Progression Marker Initiative*. PMID: 29572948; PMCID: PMC6001458.
      View in: PubMed   Mentions: 111     Fields:    Translation:Humans
    126. Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4). J Parkinsons Dis. 2018; 8(4):517-527. Chahine LM, Beach TG, Seedorff N, Caspell-Garcia C, Coffey CS, Brumm M, Adler CH, Serrano GE, Linder C, Mosovsky S, Foroud T, Riss H, Ecklund D, Seibyl J, Jennings D, Arnedo V, Riley L, Dave KD, Mollenhauer B, Systemic sSynuclein Sampling study. PMID: 30248065; PMCID: PMC6226302.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    127. APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease. Mov Disord. 2018 02; 33(2):289-297. Tropea TF, Xie SX, Rick J, Chahine LM, Dahodwala N, Doshi J, Davatzikos C, Shaw LM, Van Deerlin V, Trojanowski JQ, Weintraub D, Chen-Plotkin AS. PMID: 29168904; PMCID: PMC5809205.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    128. Cognition and the course of prodromal Parkinson's disease. Mov Disord. 2017 Nov; 32(11):1640-1645. Weintraub D, Chahine LM, Hawkins KA, Siderowf A, Eberly S, Oakes D, Seibyl J, Stern MB, Marek K, Jennings D, PARS Investigators. PMID: 29063713; PMCID: PMC5722226.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    129. Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort. J Neurol Neurosurg Psychiatry. 2018 01; 89(1):78-88. Simuni T, Caspell-Garcia C, Coffey CS, Weintraub D, Mollenhauer B, Lasch S, Tanner CM, Jennings D, Kieburtz K, Chahine LM, Marek K. PMID: 28986467; PMCID: PMC5732865.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    130. Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next? Mov Disord Clin Pract. 2017 Nov-Dec; 4(6):796-805. Chahine LM, Stern MB. PMID: 30363472; PMCID: PMC6174521.
      View in: PubMed   Mentions: 8     Fields:    
    131. Cognitive behavioral therapy for insomnia in Parkinson's disease: a case series. NPJ Parkinsons Dis. 2017; 3:25. Humbert M, Findley J, Hernandez-Con M, Chahine LM. PMID: 28765835; PMCID: PMC5533748.
      View in: PubMed   Mentions: 10  
    132. Portable objective assessment of upper extremity motor function in Parkinson's disease. Parkinsonism Relat Disord. 2017 Oct; 43:61-66. Chahine LM, Uribe L, Hogarth P, McNames J, Siderowf A, Marek K, Jennings D. PMID: 28747279.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    133. Treatment of Sleep Dysfunction in Parkinson's Disease. Curr Treat Options Neurol. 2017 Jul; 19(7):26. Amara AW, Chahine LM, Videnovic A. PMID: 28567500; PMCID: PMC6371969.
      View in: PubMed   Mentions: 29  
    134. Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease. PLoS One. 2017; 12(5):e0175674. Caspell-Garcia C, Simuni T, Tosun-Turgut D, Wu IW, Zhang Y, Nalls M, Singleton A, Shaw LA, Kang JH, Trojanowski JQ, Siderowf A, Coffey C, Lasch S, Aarsland D, Burn D, Chahine LM, Espay AJ, Foster ED, Hawkins KA, Litvan I, Richard I, Weintraub D, Parkinson’s Progression Markers Initiative (PPMI). PMID: 28520803; PMCID: PMC5435130.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    135. The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease. Biomark Med. 2017 Apr; 11(4):359-368. Visanji NP, Mollenhauer B, Beach TG, Adler CH, Coffey CS, Kopil CM, Dave KD, Foroud T, Chahine L, Jennings D, Systemic Synuclein Sampling Study (S4). PMID: 28353371.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    136. Statins and Cognition in Parkinson's Disease. J Parkinsons Dis. 2017; 7(4):661-667. Deck BL, Rick J, Xie SX, Chen-Plotkin A, Duda JE, Morley JF, Chahine LM, Dahodwala N, Trojanowski JQ, Weintraub D. PMID: 28922167; PMCID: PMC5675567.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    137. Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder. Parkinsonism Relat Disord. 2016 06; 27:102-6. Chahine LM, Xie SX, Simuni T, Tran B, Postuma R, Amara A, Oertel WH, Iranzo A, Scordia C, Fullard M, Linder C, Purri R, Darin A, Rennert L, Videnovic A, Del Riva P, Weintraub D. PMID: 27010070; PMCID: PMC5031362.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    138. Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measures. Parkinsonism Relat Disord. 2011 Mar; 17(3):208-11. Chahine LM, Ahmed A, Sun Z. PMID: 21216651.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    139. Rasagiline in Parkinson's disease. Int Rev Neurobiol. 2011; 100:151-68. Chahine LM, Stern MB. PMID: 21971007.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    140. Mental health care in Lebanon: policy, plans and programmes. East Mediterr Health J. 2009 Nov-Dec; 15(6):1596-612. Chahine LM, Chemali Z. PMID: 20218153.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    141. Palliative care needs of patients with neurologic or neurosurgical conditions. Eur J Neurol. 2008 Dec; 15(12):1265-72. Chahine LM, Malik B, Davis M. PMID: 19049542.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    142. Older adult care in Lebanon: towards stronger and sustainable reforms. East Mediterr Health J. 2008 Nov-Dec; 14(6):1466-76. Chemali Z, Chahine LM, Sibai AM. PMID: 19161123.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    143. Dementia and depression among nursing home residents in Lebanon: a pilot study. Int J Geriatr Psychiatry. 2007 Apr; 22(4):283-5. Chahine LM, Bijlsma A, Hospers AP, Chemali Z. PMID: 16977675.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    144. Familial mesial temporal lobe epilepsy maps to chromosome 4q13.2-q21.3. Neurology. 2007 Jun 12; 68(24):2107-12. Hedera P, Blair MA, Andermann E, Andermann F, D'Agostino D, Taylor KA, Chahine L, Pandolfo M, Bradford Y, Haines JL, Abou-Khalil B. PMID: 17377072.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    145. Hyperekplexia in Kurdish families: a possible GLRA1 founder mutation. Neurology. 2006 Jul 11; 67(1):137-9. Sirén A, Legros B, Chahine L, Misson JP, Pandolfo M. PMID: 16832093.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    146. Du rire aux larmes: pathological laughing and crying in patients with traumatic brain injury and treatment with lamotrigine. Epilepsy Behav. 2006 May; 8(3):610-5. Chahine LM, Chemali Z. PMID: 16504590.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Lana's Networks
    Concepts (295)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (27)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.